The federally-funded End Stage Renal Disease program was initiated in 1972 with the goal of extending the lives of individuals with kidney disease and allowing them to return to the work force. Though dialysis has prolonged the lives of patients with ESRD, it has not produced the expected degree of occupational and physical rehabilitation. A recent study showed that more than one third of hemodialysis patients had a Karnofsky score below 70, meaning that they were unable to perform the normal activities of daily living without assistance. Investigation into the causes of this striking debility has been limited, but muscle atrophy and concomitant weakness probably contribute. Reduced lean body mass (LBM) and muscle weakness have been demonstrated in this population. Since muscle strength correlates with performance measures such as gait speed in elderly subjects, the reduction in LBM in dialysis patients may affect functional status, and treatments designed to increase muscle size and strength could be of benefit to such individuals. Both anabolic steroid treatment and resistance exercise training (RE) increase strength and muscle mass in healthy subjects. RE also resulted in improved functional status in frail elderly subjects. While there have been no reports of the effects of RE in patients on dialysis, we recently showed that nandrolone decanoate (ND), a 19-nortestosterone derivative, increased LBM and improved walking and stair-climbing time in patients on dialysis. Furthermore, ND was safe in this population and resulted in only occasional mild side effects. In the current application, we propose to perform two studies concurrently. In one, to elucidate the mechanisms of the muscle defects of dialysis patients, healthy control subjects and patients on dialysis will undergo measurement of physical activity levels, and of muscle size, strength, and oxidative capacity. In the second, we will determine whether RE and/or anabolic steroids can increase muscle size and improve muscle strength and physical performance in patients on hemodialysis. In a 12-week study, 80 hemodialysis patients will be randomly assigned to one of 4 groups as follows: ND, weekly ND injections; EX, resistance exercise training plus placebo injections; ND-EX, ND injections plus RE; and PL, placebo injections only.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056182-04
Application #
6524421
Study Section
Geriatrics and Rehabilitation Medicine (GRM)
Program Officer
Eggers, Paul Wayne
Project Start
1999-09-01
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$320,006
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Gordon, P L; Doyle, J W; Johansen, K L (2011) Postdialysis fatigue is associated with sedentary behavior. Clin Nephrol 75:426-33
Wetmore, James B; Lovett, David H; Hung, Adriana M et al. (2008) Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients. Nephrology (Carlton) 13:593-600
Gordon, Patricia L; Sakkas, Giorgos K; Doyle, Julie W et al. (2007) Relationship between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr 17:397-407
Johansen, Kirsten L; Painter, Patricia L; Sakkas, Giorgos K et al. (2006) Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. J Am Soc Nephrol 17:2307-14
Walter, Louise C; Lindquist, Karla; O'Hare, Ann M et al. (2006) Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 166:1203-8
Sakkas, Giorgos K; Kent-Braun, Jane A; Doyle, Julie W et al. (2006) Effect of diabetes mellitus on muscle size and strength in patients receiving dialysis therapy. Am J Kidney Dis 47:862-9
Wetmore, James B; Johansen, Kirsten L; Sen, Saunak et al. (2006) An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease. Hum Genet 120:201-10
Wetmore, James B; Hung, Adriana M; Lovett, David H et al. (2005) Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 68:278-84
Johansen, Kirsten L; Doyle, Julie; Sakkas, Giorgos K et al. (2005) Neural and metabolic mechanisms of excessive muscle fatigue in maintenance hemodialysis patients. Am J Physiol Regul Integr Comp Physiol 289:R805-13
Johansen, Kirsten L (2005) Exercise and chronic kidney disease: current recommendations. Sports Med 35:485-99

Showing the most recent 10 out of 12 publications